Recruiting NCT07325864

Molecular Phenotyping of Primitive Lung Cancer and Metastatic Site

— Observational NSCLC Lung Cancer (Diagnosis)

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied: This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to: Registry conditions: NSCLC, Lung Cancer (Diagnosis). Basic parameters: from 18 years · All.
What needs checking: Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place: Italy
Next step: Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

investigate the molecular differences between primitive lung cancer and the metastatic site.

To investigate the molecular differences between primitive lung cancer and the metastatic site. [Time frame: From baseline to 18 months]

patients aged ≥18 years fit enough to tolerate the surgical operation;
the operative risk is considered low based on respiratory reserve and cardiac assessment;
the patient has clearly expressed willingness to adhere;
availability of pathological material for tumor DNA extraction and NGS execution.

Women of childbearing age, pregnant or breastfeeding, or intending to become pregnant during the study.
Any other illness, metabolic disorder, physical examination, or laboratory findings that constitute a contraindication to study participation.
Recent or ongoing severe or clinically significant infection.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Italy · 1 center

NCT: NCT07325864 · UID 4058 · IEO 1956